Abstract

Neuromyelitis optica spectrum disorders (NMOSD) comprise a variety of disorders being described by optic neuritis and myelitis. This disorder is mostly observed in sporadic form, yet 3% of cases are familial NMO. Different series of familial NMO cases have been reported up to now, with some of them being associated with certain HLA haplotypes. Assessment of HLA allele and haplotypes has also revealed association between some alleles within HLA-DRB1 or other loci and sporadic NMO. More recently, genome-wide SNP arrays have shown some susceptibility loci for NMO. In the current manuscript, we review available information about the role of genetic factors in NMO.

Highlights

  • Neuromyelitis optica spectrum disorders (NMOSD) comprise a variety of disorders being described by acute inflammatory responses in the optic nerve and spinal cord, i.e., optic neuritis and myelitis, respectively [1]

  • We review available information about the role of genetic factors in NMO

  • There was no correlation between distribution of HLA alleles and IgG antibody subgroups HLA-DRB1*10 allele was significantly associated with NMO disease

Read more

Summary

INTRODUCTION

Neuromyelitis optica spectrum disorders (NMOSD) comprise a variety of disorders being described by acute inflammatory responses in the optic nerve and spinal cord, i.e., optic neuritis and myelitis, respectively [1]. Most of the NMOassociated genetic factors have been enriched pathways related with nervous system and immune responses [43] Another genome-wide study using an SNP array has identified the rs1964995 in the MHC region as a risk locus for TABLE 1 | Summary of the results of family studies in neuromyelitis optica [HLA, human leukocyte antigen, AQP4-Ab, aquaporin-4 antibody (NMO-IgG)]. Matiello et al have compared genotype frequencies of 8 SNPs within AQP4 gene in sporadic and familial NMO cases as well as healthy controls. One of these SNPs has been found to be associated with risk of NMO.

65 NMO patients and 100 healthy controls
30 NMO patients and 93 controls
SNPs in AQP4
72 NMO patients
90 NMO patients and Korean
SNPs in FCRL3
13 SNPs in IL7RA 98 NMO patients and Korean
DISCUSSION
65 NMO patients and Israelis 37 healthy controls mRNAs profile
23 NMO patients and Turkish 19 healthy controls
42 NMOSD patients Japanese and 30 ONND patients
21 NMO patients and 16 healthy controls 21 NMO patients and 12 healthy controls
18 NMOSD and 8 healthy controls
20 NMO patients and 20 healthy controls
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.